During the initial stages of IPF, there is activation of chronic inflammation and the release of pro-inflammatory factors such as IL-6 and TNF-α, as well as pro-fibrotic factors like TGF-β. This evidence concerns the gene TNF and idiopathic pulmonary fibrosis.